Barclays PLC Senseonics Holdings, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Barclays PLC holds 20 shares of SENS stock, worth $9. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 20 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$0.32 - $0.49 $125 - $192	-393 Reduced 95.16%	20 $0
Q2 2024 Aug 14, 2024	BUY	$0.37 - $0.52 $145 - $204	393 Added 1965.0%	413 $0
Q4 2023 Feb 15, 2024	BUY	$0.48 - $0.7 $9 - $14	20 New	20 $0
Q1 2023 May 04, 2023	BUY	$0.68 - $1.25 $76,190 - $140,056	112,045 Added 88.24%	239,029 $170,000
Q4 2022 Feb 13, 2023	BUY	$0.96 - $1.34 $103,259 - $144,133	107,562 Added 553.82%	126,984 $131,000
Q3 2022 Nov 03, 2022	SELL	$1.02 - $2.23 $411,642 - $899,963	-403,571 Reduced 95.41%	19,422 $26,000
Q2 2022 Aug 12, 2022	BUY	$0.94 - $1.94 $330,009 - $681,083	351,074 Added 488.15%	422,993 $436,000
Q1 2022 May 16, 2022	SELL	$1.54 - $3.71 $839,991 - $2.02 Million	-545,449 Reduced 88.35%	71,919 $141,000
Q4 2021 Feb 14, 2022	BUY	$2.58 - $3.91 $1.14 Million - $1.72 Million	440,728 Added 249.51%	617,368 $1.65 Million
Q3 2021 Nov 09, 2021	BUY	$2.77 - $4.05 $343,709 - $502,536	124,083 Added 236.09%	176,640 $599,000
Q2 2021 Aug 13, 2021	BUY	$1.71 - $4.14 $46,884 - $113,510	27,418 Added 109.07%	52,557 $202,000
Q1 2021 May 13, 2021	BUY	$0.85 - $5.27 $21,368 - $132,482	25,139 New	25,139 $66,000
Q3 2020 Nov 12, 2020	SELL	$0.36 - $0.53 $12,622 - $18,582	-35,062 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$0.39 - $0.69 $67,531 - $119,479	-173,158 Reduced 83.16%	35,062 $14,000
Q1 2020 May 13, 2020	BUY	$0.56 - $1.62 $23,513 - $68,020	41,988 Added 25.26%	208,220 $132,000
Q4 2019 Feb 10, 2020	BUY	$0.83 - $1.3 $36,988 - $57,934	44,565 Added 36.63%	166,232 $152,000
Q3 2019 Nov 14, 2019	BUY	$0.97 - $1.94 $28,891 - $57,782	29,785 Added 32.42%	121,667 $121,000
Q2 2019 Aug 14, 2019	BUY	$1.81 - $2.45 $65,315 - $88,410	36,086 Added 64.67%	91,882 $187,000
Q1 2019 May 15, 2019	BUY	$2.3 - $3.27 $128,330 - $182,452	55,796 New	55,796 $137,000
Q4 2018 Feb 14, 2019	SELL	$2.49 - $4.54 $115,872 - $211,268	-46,535 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.4 - $4.84 $46,403 - $66,056	-13,648 Reduced 22.68%	46,535 $222,000
Q2 2018 Aug 14, 2018	SELL	$3.03 - $4.98 $73,983 - $121,596	-24,417 Reduced 28.86%	60,183 $247,000
Q1 2018 May 15, 2018	SELL	$2.48 - $3.21 $216,970 - $280,836	-87,488 Reduced 50.84%	84,600 $254,000
Q4 2017 Feb 14, 2018	BUY	$2.43 - $3.54 $319,272 - $465,113	131,388 Added 322.82%	172,088 $458,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $3.2 $90,354 - $130,240	40,700	40,700 $130,000

Others Institutions Holding SENS

# of Institutions

142

Shares Held

59.9M

Call Options Held

393K

Put Options Held

254K

View Full List

About Senseonics Holdings, Inc.

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $214M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

More about SENS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account